We are live on ! Find out more
VCM

Versant Capital Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
+13.52%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.39%
AUM
$1.12B
AUM Growth
+$101M
Cap. Flow
+$19.1M
Cap. Flow %
1.71%
Top 10 Hldgs %
31.56%
Holding
2,873
New
96
Increased
1,181
Reduced
859
Closed
128

Top Buys

Rank Stock Value
1
DXUV
Dimensional US Vector Equity ETF
DXUV
+$8.37M
2
DFEM icon
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
+$7.66M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$6.75M
4
DXIV
Dimensional International Vector Equity ETF
DXIV
+$4.35M
5
DFEV icon
Dimensional Emerging Markets Value ETF
DFEV
+$2.47M

Top Sells

Rank Stock Value
1
IEI icon
iShares 3-7 Year Treasury Bond ETF
IEI
+$2.11M
2
IGIB icon
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
+$2.02M
3
VTI icon
Vanguard Total Stock Market ETF
VTI
+$1.88M
4
CXW icon
CoreCivic
CXW
+$1.84M
5
AAPL icon
Apple
AAPL
+$1.34M

Sector Composition

Rank Sector Weight
1 Technology 19.06%
2 Financials 7.05%
3 Industrials 6.04%
4 Consumer Discretionary 4.74%
5 Healthcare 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMDX icon
2851
Transmedics
TMDX
$2.44B
– –
-19
Closed -$1.89K
TPH
2852
DELISTED
Tri Pointe Homes
TPH
– –
-1,738
Closed -$81.2K
TRNS icon
2853
Transcat
TRNS
$822M
– –
-6
Closed -$441
TRVI icon
2854
Trevi Therapeutics
TRVI
$2.5B
– –
-232
Closed -$2.77K
UDMY
2855
DELISTED
Udemy
UDMY
– –
-4,415
Closed -$20.4K
USMC icon
2856
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.53B
– –
-1,200
Closed -$77.2K
USPH icon
2857
US Physical Therapy
USPH
$1.1B
– –
-21
Closed -$1.57K
UWMC icon
2858
UWM Holdings
UWMC
$594M
– –
-4
Closed -$14
VRE
2859
DELISTED
Veris Residential
VRE
– –
-5,008
Closed -$94.5K
VYGR icon
2860
Voyager Therapeutics
VYGR
$180M
– –
-617
Closed -$2.38K
XBI icon
2861
State Street SPDR S&P Biotech ETF
XBI
$10.3B
– –
-900
Closed -$115K
XLB icon
2862
State Street Materials Select Sector SPDR ETF
XLB
$8.35B
– –
-1,148
Closed -$57.4K
LOAR icon
2863
Loar Holdings
LOAR
$6.58B
– –
-51
Closed -$2.92K
NNE
2864
Nano Nuclear Energy
NNE
$883M
– –
-38
Closed -$778
SUNS
2865
Sunrise Realty Trust
SUNS
$107M
– –
-483
Closed -$3.71K
MBX
2866
MBX Biosciences
MBX
$2.95B
– –
-24
Closed -$716
UPB
2867
Upstream Bio Inc
UPB
$349M
– –
-762
Closed -$6.86K
QVCGA
2868
DELISTED
QVC Group Inc Series A
QVCGA
$0 ﹤0.01%
3
– –
NAGE
2869
Niagen Bioscience
NAGE
$254M
– –
-69
Closed -$304
JBS
2870
JBS N.V.
JBS
$39.5B
– –
-117
Closed -$2.1K
SLDE
2871
Slide Insurance Holdings
SLDE
$2.24B
– –
-58
Closed -$1.04K
FIGR
2872
Figure Technology Solutions
FIGR
$6.39B
– –
-9
Closed -$306
111 112 113 114
115

Similar funds

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
NOSC
North of South Capital London, United Kingdom $1.11B AUM 16.64% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
ACG
Allen Capital Group Grand Island, Nebraska $1.12B AUM 13.85% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Versant Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Versant Capital Management held 2,873 positions worth $1.12B, up 10% from $1.01B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Versant Capital Management's Q2 2026 filing shows 96 new, 1,181 increased, 859 reduced and 128 closed positions. Its largest new stake was AstraZeneca: 7,263 shares worth $1.36M. The largest sale was iShares 3-7 Year Treasury Bond ETF, an estimated $2.11M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.

  • Versant Capital Management's largest Q2 2026 buy was AstraZeneca: 7,263 shares worth $1.36M.
  • Versant Capital Management added most to Dimensional US Vector Equity ETF in Q2 2026, an estimated $8.37M increase.
  • Versant Capital Management's biggest Q2 2026 reduction was iShares 3-7 Year Treasury Bond ETF, cutting an estimated $2.11M.
  • Versant Capital Management fully exited iShares 5-10 Year Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $2.02M.
  • Versant Capital Management's ten largest holdings make up 32% of its $1.12B portfolio in Q2 2026.
  • Versant Capital Management opened 96 new positions and closed 128 in Q2 2026.
  • Versant Capital Management's portfolio value rose 10% quarter-over-quarter to $1.12B.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.